PRKCA and lung carcinoma: In an experiment using the carcinogen nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), which is produced by the nitrosation of nicotine, PKCι activation enhanced the survival and chemoresistance of human lung cancer cells by increasing NNK-induced Bad phosphorylation [221].